Premium
EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON‐SMALL CELL LUNG CANCER PATIENTS
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13420_542
Subject(s) - medicine , chemotherapy , lung cancer , oncology , programmed cell death 1 , salvage therapy , immune checkpoint , nivolumab , immune system , immunotherapy , pd l1 , cancer , cancer research , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom